SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001564590-22-004950
Filing Date
2022-02-14
Accepted
2022-02-14 16:05:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A vir-sc13ga.htm SC 13G/A 65827
  Complete submission text file 0001564590-22-004950.txt   67133
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY SAN FRANCISCO CA 94083
Business Address
SCANGOS GEORGE A (Filed by) CIK: 0001202102 (see all company filings)

Type: SC 13G/A

Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Subject) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91177 | Film No.: 22631343
SIC: 2836 Biological Products, (No Diagnostic Substances)